MELISSA SHENE: Open Payments
NPI 1831290295 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 17 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $617
Food & beverage: $438Education: $179
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $179 |
| Geron Corporation | 1 | $129 |
| Rigel Pharmaceuticals, Inc. | 4 | $90 |
| ABBVIE INC. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Exelixis Inc. | 1 | $22 |
| Genmab U.S., Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
Products named: RYTELO, TAVALISSE, VENCLEXTA, JEMPERLI, KISQALI, Enhertu, CABOMETYX, Epkinly.
Industry payments across PA — which companies pay providers there.
